Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2

被引:8
|
作者
Militaru, Marius [1 ,2 ,3 ]
Lighezan, Daniel Florin [2 ,3 ,4 ]
Tudoran, Cristina [5 ,6 ,7 ]
Militaru, Anda Gabriela [2 ,3 ,4 ]
机构
[1] Univ Med & Pharm Victor Babes Timisoara, Dept 8, Pharm Victor Babes Timisoara, Discipline Neurol 2, E Murgu Sq 2, Timisoara 300041, Romania
[2] Municipal Emergency Hosp Timisoara, Clin Thorac Surg, Gheorghe Dima St 5, Timisoara 300254, Romania
[3] Univ Med & Pharm Victor Babes Timisoara, Ctr Adv Res Cardiol & Hemostasol, E Murgu Sq, 2, Timisoara 300041, Romania
[4] Univ Med & Pharm Victor Babes Timisoara, Dept 5, Discipline Med Semiol 1, E Murgu Sq, 2, Timisoara 300041, Romania
[5] Univ Med & Pharm Victor Babes Timisoara, Dept 7, Discipline Cardiol, E Murgu Sq 2, Timisoara 300041, Romania
[6] Univ Med & Pharm Victor Babes Timisoara, Ctr Mol Res Nephrol & Vasc Dis, E Murgu Sq 2, Timisoara 300041, Romania
[7] Cty Emergency Hosp Pius Brinzeu, L Rebreanu 156, Timisoara 300723, Romania
关键词
diabetes mellitus; atrial fibrillation; cognitive decline; dementia; subclinical atherosclerosis; memory tests; TRIGLYCERIDE GLUCOSE INDEX; ASSOCIATION; DEMENTIA; MORTALITY; DECLINE; DISEASE;
D O I
10.3390/biomedicines12030672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(1) Background: Cognitive decline (CD), considered a precursory state of dementia, is frequently encountered in patients with diabetes mellitus type 2 (DM-2) and might even have a higher prevalence in those with associated atrial fibrillation (AF). In this study, we aimed to research if the association of DM-2 and AF favors a precocious onset of CD. (2) Methods: This study was conducted on 160 patients, featuring 50 with DM-2, 54 with DM-2 and AF, and 56 subjects without DM-2 and AF, all evaluated clinically and with five neuropsychiatric scales. (3) Results: The Mini-Mental-State-Examination (MMSE), Montreal Cognitive Assessment (MoCA), Activities of Daily Living Score (ADL), Instrumental Activities of Daily Living Score (IADL), and Geriatric Depression Scale (GDS-15) were significantly altered in patients with DM-2 and AF in comparison to patients without these diseases. The logistic regression model indicated that, in patients with DM-2 and AF, an increase of one year in age is associated with a 7.3% augmentation of the risk of a precocious onset of CD (MMSE < 27). (4) Conclusions: CD is more frequent in patients with DM-2, especially when associated with AF, versus those without DM-2 and AF. Our findings suggest that an older age and associated dyslipidemia represent risk factors for CD in patients with DM-2.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Electrical Remodelling Contributes to Atrial Fibrillation in Type 2 Diabetes Mellitus
    Bohne, Loryn J.
    Jansen, Hailey J.
    Moghtadaei, Motahareh
    Rose, Robert A.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 346A - 346A
  • [42] Association between First-Line Monotherapy with Metformin and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus
    Tekin, Zehra
    Milinovich, Alex
    Ji, Xinge
    Bauman, Janine
    Kattan, Michael
    Pantalone, Kevin M.
    Zimmerman, Robert S.
    Chung, Mina K.
    Kashyap, Sangeeta
    DIABETES, 2020, 69
  • [44] Auditory impairment in patients with type 2 diabetes mellitus
    de León-Morales, LVD
    Jáuregui-Renaud, K
    Garay-Sevilla, ME
    Hernández-Prado, J
    Malacara-Hernández, JM
    ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) : 507 - 510
  • [45] Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Specific Features of Development and Antirecurrence Therapy
    Kanorsky, S. G.
    Kanorskaya, Yu. S.
    KARDIOLOGIYA, 2010, 50 (07) : 31 - 37
  • [46] Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus
    Turgut, Okan
    Zorlu, Ali
    Kilicli, Fatih
    Cinar, Ziynet
    Yucel, Hasan
    Tandogan, Izzet
    Dokmetas, Hatice Sebila
    PLATELETS, 2013, 24 (06) : 493 - 497
  • [47] Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
    Chowdhury, Krishna Roy
    Michaud, Jonathan
    Yu, Oriana Hoi Yun
    Yin, Hui
    Azoulay, Laurent
    Renoux, Christel
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1794 - 1803
  • [48] Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus
    Hoo, Y. Y.
    Mazlan-Kepli, W.
    Habizal, N. H.
    Ismail, M. I.
    Wong, Y. P.
    Rosnan, N. H.
    Mohamed, S.
    Abd Ghani, A. R.
    Yusof, H. Mohd
    Ramaiah, A. R. Abdullah
    Selvaraj, K.
    Abd Malek, A. M.
    Ghapar, A. K. Abdul
    EUROPEAN HEART JOURNAL, 2023, 44 : 152 - 152
  • [49] High bodyweight variability and increased risk of atrial fibrillation in patients with type 2 diabetes mellitus
    Lee, H. J.
    Choi, E. K.
    Han, K. D.
    Kim, D. H.
    Lee, E.
    Lee, S. R.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 474 - 474
  • [50] Correlation between Diabetes Mellitus and Cognitive Impairment
    Pakamaniene, Egle
    Kukiene, Joana
    Bagdonaite, Egle
    Urbonas, Gediminas
    DIABETES, 2017, 66 : A451 - A451